UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 12, 2021

 

ADVAXIS, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-36138   02-0563870

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

9 Deer Park Drive, Suite K-1,

Monmouth Junction, New Jersey

  08852
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (609) 452-9813

 

 
(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 per share   ADXS   Nasdaq Capital Market
Preferred Stock Purchase Rights   -   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Registered Direct Offering

 

On April 12, 2021, Advaxis, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors. The Purchase Agreement provides for the sale and issuance by the Company of an aggregate of 17,577,400 shares (the “Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”), at an offering price of $0.7921 per Share and 7,671,937 pre-funded warrants to certain purchasers whose purchase of additional Shares would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company’s outstanding Common Stock immediately following the consummation of the offering (the “Pre-Funded Warrants”). The Shares and Pre-Funded Warrants are being sold together with warrants to purchase up to 11,244,135 shares of Common Stock (the “Accompanying Warrants” and together with the Shares and the Pre-Funded Warrants, the “Securities”). The Pre-Funded Warrants are being sold for a purchase price of $0.7911 per share and will have an exercise price of $0.001 per share. The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. Each Accompanying Warrant has an exercise price per share of $0.70, will be exercisable immediately and will expire on the fifth anniversary of the original issuance date.

 

The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties and termination provisions.

 

On April 12, 2021, the Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with A.G.P./Alliance Global Partners (the “Placement Agent”). Pursuant to the terms of the Placement Agent Agreement, the Placement Agent agreed to use its reasonable best efforts to arrange for the sale of the Securities and the Private Placement Warrants (as defined below). The Company will pay the Placement Agent a cash fee equal to 6.5% of the gross proceeds generated from the sale of the Shares and Pre-Funded Warrants, excluding gross proceeds of any sale of Shares or Pre-Funded Warrants to Lincoln Park Capital Fund, LLC, and will reimburse the Placement Agent for certain of its expenses in an amount not to exceed $50,000.

 

The Placement Agent Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Placement Agent, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions.

 

Pursuant to the Purchase Agreement and the Placement Agent Agreement, the Company has agreed that (i) it will not conduct any issuances of Common Stock for a period of 60 days following closing of the offering and that (ii) it will not conduct any sales of Common Stock under its at-the-market facility or under its existing equity line with Lincoln Park Capital Fund, LLC, in each case for a period of 90 days following the closing of the offering. However, if the Company files a registration statement with the Securities and Exchange Commission (the “SEC”) with respect to the Private Placement Warrants (as defined below) and the shares of Common Stock issuable upon the exercise of such Private Placement Warrants, then such restrictions will expire on the date that is 30 days following the effectiveness of such registration statement (if such date is otherwise earlier than the expiration of the restrictions described above).

 

The issuance and sale of the Shares, the Pre-Funded Warrants and the Accompanying Warrants (the “Registered Offering”) will be made pursuant to a Registration Statement (No. 333-226988) on Form S-3, which was filed by the Company with the SEC on August 23, 2018, and declared effective on August 30, 2018, as supplemented by a prospectus supplement dated April 12, 2021.

 

 

 

 

Private Placement

 

The Purchase Agreement also provides for a concurrent private placement (the “Private Placement”) of 14,005,202 warrants to purchase the Company’s Common Stock (the “Private Placement Warrants”) with the purchasers in the Registered Offering. The Private Placement Warrants will be exercisable for an aggregate of 14,005,202 shares of Common Stock at any time on or after such date, if ever, that is fourteen (14) days after the Company files an amendment (the “Authorized Shares Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock, $0.001 par value per share from 170,000,000 shares to 300,000,000 shares with the Delaware Secretary of State and on or prior to the date that is five years after such date. The Private Placement Warrants will have an exercise price of $0.70 per share.

 

The Company has agreed to use commercially reasonable best efforts to file a registration statement on Form S-3 (or other appropriate form) providing for the resale by the purchasers of the Private Placement Warrants and the shares of Common Stock issuable upon exercise of the Private Placement Warrants as soon as practicable (and in any event within 60 calendar days) of the such date, if ever, that the Company file the Authorized Shares Amendment.

 

Investor Agreement

 

In connection with the Registered Offering and Private Placement, on April 12, 2021, the Company entered into an investor agreement (the “Investor Agreement”) with the Placement Agent and the investors in the Registered Offering and Private Placement. Pursuant to the Investor Agreement, any investor that purchases Securities in the offering, as a condition to such purchase, agrees to vote the shares of the Company’s Common Stock that such purchaser owns or controls on the record date of the Company’s 2021 annual meeting of stockholders (or any postponement, adjournment or reconvening thereof) (the “2021 Annual Meeting”) in a manner that is consistent with the recommendations of the Company’s Board of Directors on each proposal being presented for stockholder vote at the 2021 Annual Meeting. The record date for the 2021 Annual Meeting is April 15, 2021.

 

In addition, the Investor Agreement also provides that the purchasers in the Registered Offering will be restricted from selling any shares of the Company’s Common Stock purchased in the Registered Offering through April 15, 2021.

 

The Placement Agent Agreement, Purchase Agreement, the Form of Investor Agreement, form of Pre-Funded Warrant, form of Accompanying Warrant, and form of Private Placement Warrant are filed as Exhibits 1.1, 10.1, 10.2, 4.1, 4.2 and 4.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The above descriptions of the terms of the Placement Agent Agreement, Purchase Agreement, the Investor Agreement, form of Pre-Funded Warrant, form of Accompanying Warrant, and form of Private Placement Warrant are qualified in their entirety by reference to such exhibits.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information under Item 1.01 of this Current Report on Form 8-K regarding the Private Placement Warrants and the shares of Common Stock issuable upon exercise of the Private Placement Warrants is incorporated herein by reference.

 

Item 8.01 Other Events.

 

The Company issued a press release announcing the Registered Offering and the Private Placement on April 12, 2021. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
1.1   Placement Agent Agreement dated April 12, 2021, between Advaxis, Inc. and A.G.P./Alliance Global Partners.
4.1   Form of Pre-Funded Warrant.
4.2   Form of Accompanying Warrant.
4.3   Form of Private Placement Warrant.
5.1   Opinion of Morgan, Lewis & Bockius LLP.
10.1   Securities Purchase Agreement dated April 12, 2021, by and among Advaxis, Inc. and the purchasers identified on the signature pages thereto.
10.2   Form of Investor Agreement.
23.1   Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1).
99.1   Press Release of the Company dated April 12, 2021.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

April 12, 2021 ADVAXIS, INC.
     
  By: /s/ Kenneth A. Berlin
  Name: Kenneth A. Berlin
  Title: President and Chief Executive Officer, Interim Chief Financial Officer

 

 

 

Exhibit 1.1

 

April 12, 2021

 

Advaxis, Inc.

9 Deer Park Drive, Suite K-1

Monmouth Junction, NJ 08852

Attn: Kenneth Berlin

Chief Executive Officer

 

Dear Mr. Berlin:

 

This letter (the “Agreement”) constitutes the agreement between A.G.P./Alliance Global Partners (the “Placement Agent”) and Advaxis Inc., a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of the Company’s shares of Common Stock, par value $0.001 per share (the “Common Stock”), pre-funded warrants to purchase shares of common stock and warrants to purchase shares of Common Stock (collectively, the “Securities”). The Securities actually placed by the Placement Agent are referred to herein as the “Placement Agent Securities.” The terms of the Placement shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”), and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser, or an obligation for the Company will issue any Securities or complete the Placement. The Company expressly acknowledges and agrees that the Placement Agent’s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement; provided, however, that the Company shall first approve any such sub-agents. Certain affiliates of the Placement Agent may participate in the Placement by purchasing some of the Placement Agent Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced by a securities purchase agreement (the “Purchase Agreement”) between the Company and such Purchaser, in a form reasonably acceptable to the Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer inquiries from prospective Purchasers.

 

SECTION 1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY.

 

A. Representations of the Company. With respect to the Placement Agent Securities, each of the representations and warranties (together with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that there are no affiliations with any FINRA member firm among the Company’s officers, directors or, to the knowledge of the Company, any five percent (5.0%) or greater securityholder of the Company, except as set forth in the Purchase Agreement.

 

B. Covenants of the Company. The Company covenants and agrees to use commercially reasonable efforts in order to continue to retain (i) a firm of independent PCAOB registered public accountants for a period of at least five (5) years after the Closing Date and (ii) a competent transfer agent with respect to the Common Stock for a period of five (5) years after the Closing Date. In addition, From the date hereof until 60 days after the Closing Date (such applicable period, the “Restricted Period”), neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. From the date hereof until 90 days after the Closing Date (such applicable period, the “Additional Restricted Period”), neither the Company nor the Subsidiary shall conduct any sales from the Company’s Sales Agreement with the Placement Agent or any equity line transaction. Notwithstanding the foregoing, if still in effect, the Restricted Period and the Additional Restricted Period shall expire and terminate 30 days immediately following the date of effectiveness of the Registration Statement to be filed by the Company pursuant to Section 4.19 of the Purchase Agreement.

 

1
 

 

SECTION 2. REPRESENTATIONS OF THE PLACEMENT AGENT. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable to the offers and sales of the Placement Agent Securities by the Placement Agent, (iv) is and will be a corporate body validly existing under the laws of its place of incorporation, (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.

 

SECTION 3. COMPENSATION. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective designees a cash fee of 6.5% of the aggregate gross proceeds raised from the sale of the Placement Agent Securities, excluding any gross proceeds received from the sale of the Placement Agent Securities to Lincoln Park Capital Fund, LLC (the “Cash Fee”). The Cash Fee shall be paid on the Closing Date. The Company shall not be required to pay the Placement Agent any fees or expenses except for the Cash Fee, the reimbursement of up to $50,000 in legal expenses and clearing agent fees and expenses, and the reimbursement of out of pocket expenses of the Placement Agent in connection with marketing the transaction (i.e., roadshow expenses, background checks, tombstones, etc.), with respect to the engagement hereunder; provided, however, that the reimbursement of legal, and out of pocket expenses of the Placement Agent shall not exceed $50,000 in the aggregate; provided, further, that this sentence in no way limits or impairs the indemnification or contribution provisions contained herein. The Placement Agent reserves the right to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent’s aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.

 

SECTION 4. INDEMNIFICATION.

 

A. To the extent permitted by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from the Placement Agent’s willful misconduct or gross negligence in performing the services described herein.

 

B. Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company, in addition to fees of local counsel. The Company will have the right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Company shall not be liable for any settlement of any action effected without its written consent, which will not be unreasonably withheld.

 

2
 

 

C. The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding relating to a transaction contemplated by this Agreement.

 

D. If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand and the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent’s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under this Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement Agent).

 

E. These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement is completed and shall survive the termination of this Agreement, and shall be in addition to any liability that the Company might otherwise have to any indemnified party under this Agreement or otherwise.

 

SECTION 5. ENGAGEMENT TERM. The Placement Agent’s engagement hereunder will be until the earlier of (i) April 30, 2021 and (ii) the Closing Date. The date of termination of this Agreement is referred to herein as the “Termination Date.” In the event, however, in the course of the Placement Agent’s performance of due diligence it deems it necessary to terminate the engagement, the Placement Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the Termination Date but will remain responsible for fees and expenses pursuant to Section 3 hereof and fees with respect to the Placement Agent Securities if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company’s obligation to pay any fees actually earned pursuant to Section 3 hereof, to pay expenses pursuant to Section 3 hereof, and the provisions concerning confidentiality, indemnification and contribution contained herein will survive any expiration or termination of this Agreement. If this Agreement is terminated prior to the completion of the Placement, all fees and expenses due to the Placement Agent shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees are earned or owed as of the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under this Agreement.

 

SECTION 6. PLACEMENT AGENT INFORMATION. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent’s prior written consent.

 

SECTION 7. NO FIDUCIARY RELATIONSHIP. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder, all of which are hereby expressly waived.

 

3
 

 

SECTION 8. CLOSING. The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:

 

A. All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.

 

B. The Placement Agent shall have received from outside US counsel to the Company each such counsel’s written opinion with respect to the Placement Agent Securities, addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.

 

C. The Placement Agent shall have received an executed lock-up agreement from the Company’s directors prior to the Closing Date.

 

D. The Common Stock shall be registered under the Exchange Act and, as of the Closing Date, the Company shall have submitted an application for the supplemental listing of shares on the Trading Market or other applicable U.S. national exchange and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.

 

E. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.

 

F The Company shall have entered into a Purchase Agreement with each of the Purchasers of the Placement Agent Securities and such agreements shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the Company and the Purchasers.

 

G. FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested by the Placement Agent, make or authorize Placement Agent’s counsel to make on the Company’s behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 2710 with respect to the Placement and pay all filing fees required in connection therewith.

 

If any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.

 

SECTION 9. GOVERNING LAW. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

4
 

 

SECTION 10. ENTIRE AGREEMENT/MISCELLANEOUS. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.

 

SECTION 12. NOTICES. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.

 

SECTION 13. Press Announcements. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference the Placement and the Placement Agent’s role in connection therewith in the Placement Agent’s marketing materials and on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.

 

[The remainder of this page has been intentionally left blank.]

 

5
 

 

Please confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.

 

  Very truly yours,
     
  A.G.P./ALLIANCE GLOBAL PARTNERS
                         
  By: /s/ Thomas Higgins
  Name: Thomas Higgins
     
    Address for notice:
   

590 Madison Avenue 28th Floor

New York, New York 10022

Attn: Thomas Higgins

Email:

 

Accepted and Agreed to as of

the date first written above:

 

ADVAXIS, INC.  
     
By: /s/ Kenneth A. Berlin  
Name: Kenneth A. Berlin  
Title: President and Chief Executive Officer and Interim Chief Financial Officer  
     
 

Address for notice:

9 Deer Park Drive, Suite K-1,

Monmouth Junction, New Jersey

Attn: Kenneth Berlin

President and Chief Executive Officer, Interim Chief Financial Officer

 

 

[Signature Page to Placement Agent Agreement.]

 

6

  

 

Exhibit 4.1

 

PRE-FUNDED COMMON STOCK PURCHASE WARRANT

 

ADVAXIS, INC.

 

Warrant Shares: ________   Issue Date: April [___], 2021

 

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the terms of that certain Securities Purchase Agreement (the “Purchase Agreement”), dated April 12, 2021, among the Company and the Holder.

 

Section 1. Definitions. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock Equivalents” means any securities of the Company, which would entitle the holder thereof to acquire at any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Trading Day” means a day on which the principal Trading Market is open for trading.

 

Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

 

Transfer Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing address of 1 State Street, 30th Floor, New York, New York 10004 and a facsimile number of (212) 616-7619, and any successor transfer agent of the Company.

 

1

 

 

Section 2. Exercise.

 

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or.pdf copy via e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the unpaid portion of the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

b) Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The exercise price per Warrant Share shall be $0.001, subject to adjustment hereunder (the “Exercise Price”).

 

c) Cashless Exercise. If at any time after the Initial Exercise Date, there is no effective registration statement registering, or no current prospectus available for, the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

 

(B) = $0.001, as adjusted hereunder; and

 

(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c).

 

2

 

 

Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

d) Mechanics of Exercise.

 

i. Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered by 12:00 p.m. (New York City time) on the Initial Exercise Date, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder.

 

3

 

 

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided , however , that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

4

 

 

vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

5

 

 

Section 3. Certain Adjustments.

 

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) [RESERVED]

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

6

 

 

e) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of shares of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) Notice to Holder.

 

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

7

 

 

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock, (C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 5 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice and provided, further that no notice shall be required if the information is disseminated in a press release or document filed with the Securities and Exchange Commission . To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 4. Transfer of Warrant.

 

a) Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5. Miscellaneous.

 

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

8

 

 

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

 

f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the Holder’s right to exercise this Warrant terminates on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

9

 

 

j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

10

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

ADVAXIS, INC.
     
By:    
Name: Mr. Kenneth A. Berlin  
Title: President and Chief Executive Officer, Interim Chief Financial Officer  

 

11

 

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

TO: ADVAXIS, INC.

 

(1) The undersigned hereby elects to purchase _________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

     

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

     

 

     

 

     

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity:

 

   

 

Signature of Authorized Signatory of Investing Entity:

 

   

 

Name of Authorized Signatory:

 

   

 

Title of Authorized Signatory:

 

   

 

Date:

 

   

 

12

 

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name:    
  (Please Print)  
     
Address:    
  (Please Print)  
     
Phone Number:    
     
Email Address:    
     
Dated:________ _____, ______    
     
Holder’s Signature:  
     
     
     
Holder’s Address:  
     
     
     
     

 

13

 

Exhibit 4.2

 

COMMON STOCK PURCHASE WARRANT

 

ADVAXIS, INC.

 

Warrant Shares: _______ Issue Date: April [__], 2021

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April [__], 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April [__], 20261 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to _____ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Purchase Agreement”), dated April 12, 2021, among the Company and the purchasers signatory thereto.

 

Section 2. Exercise.

 

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or.pdf copy via e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the unpaid portion of the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

b) Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $0.70, subject to adjustment hereunder (the “Exercise Price”).

 

 

15 year term

 

1
 

 

c) Cashless Exercise. If at any time during the term of this Warrant, there is no effective registration statement registering, or no current prospectus available for, the issuance or resale of the Warrant Shares by the Holder, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares determined according to the following formula (a “Cashless Exercise”):

 

Net Number = (A x B) - (A x C)

  B  

 

For purposes of the foregoing formula:

 

(A) = the total number of shares with respect to which the Warrants are then being exercised.

 

(B) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day; and

 

(C) = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without limiting the rights of the Holder to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in the event the Company does not have or maintain an effective registration statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the purchase warrants to the holders.

 

Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

2
 

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

d) Mechanics of Exercise.

 

i. Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

3
 

 

iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

4
 

 

vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

5
 

 

Section 3. Certain Adjustments.

 

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) Reserved.

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

6
 

 

e) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of shares of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

7
 

 

f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) Notice to Holder.

 

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock, (C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 5 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice and provided, further that no notice shall be required if the information is disseminated in a press release or document filed with the Securities and Exchange Commission .. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

8
 

 

Section 4. Transfer of Warrant.

 

a) Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5. Miscellaneous.

 

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized Shares.

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

9
 

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

 

f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the Holder’s right to exercise this Warrant terminates on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant or the Purchase Agreement, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

10
 

 

j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

11
 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

  ADVAXIS, INC.
   
  By:         
  Name:  
  Title:  

 

12
 

 

NOTICE OF EXERCISE

 

TO: ADVAXIS, INC.

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

     

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

     
     
     
     
     

 

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

_____________________

_____________________

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________

Signature of Authorized Signatory of Investing Entity: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

 

13
 

 

Exhibit B

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name:    
    (Please Print)
Address:    
    (Please Print)
     
Phone Number:    
     
Email Address:    
     
Dated: _______________ __, ______    
     
Holder’s Signature:______________________    
     
Holder’s Address:______________________    

 

14

 

 

Exhibit 4.3

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

ADVAXIS, INC.

 

Warrant Shares: _______ Initial Exercise Date: Specified Below
   
  Issue Date: April ___, 2021

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after such date, if ever, that is fourteen (14) days after the Company (as defined below) files an amendment to the Company’s Amended and Restated Certificate of Incorporation (as amended to date, the “Charter”) to increase the number of authorized shares of common stock, $0.001 par value per share from 170,000,000 shares to 300,000,000 shares (the “Authorized Shares Amendment”) with the Delaware Secretary of State (the “Initial Exercise Date”) and on or prior to the date that is five years after the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to _____ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Purchase Agreement”), dated April 12, 2021, among the Company and the purchasers signatory thereto.

 

Section 2. Exercise.

 

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or.pdf copy via e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the unpaid portion of the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

1
 

 

b) Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $0.70, subject to adjustment hereunder (the “Exercise Price”).

 

c) Cashless Exercise. If at any time during the term of this Warrant, there is no effective registration statement registering, or no current prospectus available for, the issuance or resale of the Warrant Shares by the Holder, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares determined according to the following formula (a “Cashless Exercise”):

 

Net Number = (A x B) - (A x C)

                                     B

 

For purposes of the foregoing formula:

 

(A) = the total number of shares with respect to which the Warrants are then being exercised.

 

(B) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day; and

 

(C) = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without limiting the rights of the Holder to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in the event the Company does not have or maintain an effective registration statement, there are no circumstances that would require the Company to make any cash payments or net cash settle the purchase warrants to the holders.

 

Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

2
 

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

d) Mechanics of Exercise.

 

i. Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

3
 

 

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

4
 

 

vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

5
 

 

Section 3. Certain Adjustments.

 

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) Reserved.

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

6
 

 

d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

e) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of shares of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of shares of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

7
 

 

f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) Notice to Holder.

 

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the shares of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of Common Stock, (C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the shares of Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares of Common Stock are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 5 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or stock exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice and provided, further that no notice shall be required if the information is disseminated in a press release or document filed with the Securities and Exchange Commission .. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

8
 

 

Section 4. Transfer of Warrant.

 

a) Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d) Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

 

e) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5. Miscellaneous.

 

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

9
 

 

b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized Shares.

 

The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the shares of Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

 

10
 

 

f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the Holder’s right to exercise this Warrant terminates on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant or the Purchase Agreement, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

11
 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

  ADVAXIS, INC.
   
  By:         
  Name:  
  Title:  

 

12
 

 

NOTICE OF EXERCISE

 

TO: ADVAXIS, INC.

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

     

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

     
     
     
     
     

 

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

_____________________

_____________________

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________

Signature of Authorized Signatory of Investing Entity: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

 

13
 

 

Exhibit B

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name:    
    (Please Print)
Address:    
    (Please Print)
     
Phone Number:    
     
Email Address:    
     
Dated: _______________ __, ______    
     
Holder’s Signature:______________________    
     
Holder’s Address:______________________    

 

14

 

 

Exhibit 5.1

 

 

April 12, 2021

 

Advaxis, Inc.

9 Deer Park Drive, Suite K-1

Monmouth Junction, NJ 08852

 

Re: Advaxis, Inc., Registration Statement on Form S-3 (File No. 333-226988)

 

Ladies and Gentlemen:

 

We have acted as counsel for Advaxis, Inc., a Delaware corporation (the “Company”), in connection with the issuance and sale by the Company of (a) 17,577,400 shares (the “Shares”) of its Common Stock, par value $0.001 per share (the “Common Stock”), pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 7,671,937 shares of Common Stock (and such shares issuable upon exercise of the Pre-Funded Warrants, the “Pre-Funded Warrant Shares”) and warrants (the “Accompanying Warrants”) to purchase up to 11,244,135 shares of Common Stock (such shares issuable upon exercise of the Accompanying Warrants, the “Accompanying Warrant Shares”), pursuant to that certain Securities Purchase Agreement, dated April 12, 2021, by and among the Company and the several purchasers named therein (the “Purchase Agreement”), for which A.G.P./Alliance Global Partners (“A.G.P.”) acted as placement agent (the “Placement Agent”), pursuant to a Placement Agent Agreement, dated April 12, 2021, by and between the Company and A.G.P. (the “Placement Agent Agreement”).

 

In connection with this opinion letter, we have examined the Company’s registration statement on Form S-3 (Registration No. 333-226988) (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective on August 30, 2018, the Prospectus Supplement, dated April 12, 2021 (the “Prospectus Supplement”) and the accompanying base prospectus dated August 30, 2018 (together with the Prospectus Supplement, the “Prospectus”), certain resolutions of the Company’s Board of Directors and a Pricing Committee of the Board of Directors relating to the offering, the form of the Pre-Funded Warrants, the form of the Accompanying Warrants and originals, or copies certified or otherwise identified to our satisfaction, of the Amended and Restated Certificate of Incorporation, as amended, the Second Amended and Restated Bylaws of the Company, the Purchase Agreement, the Placement Agent Agreement, and such other authorities, documents, records and other instruments as we have deemed appropriate for purposes of the opinion set forth herein.

 

We have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of the documents submitted to us as originals, the conformity with the originals of all documents submitted to us as certified, facsimile or photostatic copies and the authenticity of the originals of all documents submitted to us as copies.

 

 

 
 

 

Based upon the foregoing, we are of the opinion that (i) the Shares, when issued and sold by the Company and delivered by the Company against receipt of the purchase price therefor, in the manner contemplated by the Prospectus and the Purchase Agreement will be validly issued, fully paid and non-assessable; (ii) when the Pre-Funded Warrants and the Accompanying Warrants are issued, sold and delivered in the manner and for the consideration stated in the Registration Statement and the Prospectus, such Pre-Funded Warrants and Accompanying Warrants will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equity principles; (iii) the Pre-Funded Warrant Shares, when issued and delivered by the Company upon exercise and payment of the purchase price therefor and the exercise price of the Pre-Funded Warrants, in accordance with the terms thereof, will be validly issued, fully paid and non-assessable; and (iv) the Accompanying Warrant Shares, when issued and delivered by the Company upon exercise and payment of the exercise price of the Accompanying Warrants, in accordance with the terms thereof, will be validly issued, fully paid and non-assessable.

 

Our opinion is limited solely to the Delaware General Corporation Law and the laws of the State of New York without regard to choice of law, to the extent that the same may apply to or govern the transactions contemplated by the Registration Statement. We express no opinion as to the effect of events occurring, circumstances arising, or changes of law becoming effective or occurring, after the date hereof on the matters addressed in this opinion.

 

We hereby consent to the use of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to us under the caption “Legal Matters” in the Prospectus Supplement. In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent is required under Section 7 of the Securities Act or the rules or regulations of the Commission thereunder.

 

 

Very truly yours,

 

/s/ Morgan, Lewis & Bockius LLP

 

 

 

 

 

 

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of April 12, 2021 between Advaxis, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”) as to the Shares, Pre-Funded Warrants and Registered Warrants and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Unregistered Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:

 

Acquiring Person” shall have the meaning ascribed to such term in Section 4.5.

 

Action” shall have the meaning ascribed to such term in Section 3.1(j).

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

Board of Directors” means the board of directors of the Company.

 

Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

Closing Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd) Trading Day following the date hereof.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

1
 

 

Company Counsel” means Morgan, Lewis & Bockius LLP, 502 Carnegie Center, Princeton, NJ 08540.

 

Disclosure Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.

 

Disclosure Time” means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof.

 

Evaluation Date” shall have the meaning ascribed to such term in Section 3.1(s).

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

 

FDA” shall have the meaning ascribed to such term in Section 3.1(hh).

 

FDCA” shall have the meaning ascribed to such term in Section 3.1(hh).

 

GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

 

Indebtedness” shall have the meaning ascribed to such term in Section 3.1(aa).

 

Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(p).

 

Investor Agreement” means the form of investor agreement in the form of Exhibit D attached hereto.

 

Legend Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

Lock-Up Agreement” means the Lock-Up Agreement for a period of 90 days following the Closing Date, executed by each of the directors and officers of the Company.

 

Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

Material Permits” shall have the meaning ascribed to such term in Section 3.1(n).

 

Per Share Purchase Price” equals $0.7921, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Pharmaceutical Product” shall have the meaning ascribed to such term in Section 3.1(hh).

 

Placement Agent” means A.G.P./Alliance Global Partners.

 

2
 

 

Placement Agent Agreement” means that certain placement agent agreement dated as of the date hereof between the Company and the Placement Agent.

 

Pre-Funded Warrants” means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of Exhibit C attached hereto.

 

Pre-Funded Warrant Shares” means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.

 

Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition) pending or, to the Company’s knowledge, threatened in writing against or affecting the Company, or its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign).

 

Prospectus” means the final prospectus filed for the Registration Statement.

 

Prospectus Supplement” means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.

 

Purchaser Party” shall have the meaning ascribed to such term in Section 4.8.

 

Registration Statement” means the effective registration statement with Commission File No. 333-226998 which registers the sale of the Shares, Pre-Funded Warrants, Pre-Funded Warrant Shares, Registered Warrants and Registered Warrant Shares.

 

Registered Warrant” means the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Warrants shall be exercisable on date of issuance and have a term of exercise equal to five (5) years from date of initial exercisability, in the form of Exhibit A attached hereto.

 

Registered Warrant Shares” means the shares of Common Stock issuable upon exercise of the Registered Warrants.

 

Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

SEC Reports” shall have the meaning ascribed to such term in Section 3.1(h).

 

Securities” means the Shares, the Warrants and the Warrant Shares.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

3
 

 

Shares” means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.

 

Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).

 

Stockholder Approval” means the necessary approval of the stockholders of the Company to increase the Company’s authorized share capital to permit the exercise of the Unregistered Warrants.

 

Subscription Amount” means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds.

 

Subsidiary” means any subsidiary of the Company, and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.

 

Sullivan” means Sullivan & Worcester LLP, with offices located at 1633 Broadway, New York, New York 10019.

 

Trading Day” means a day on which the principal Trading Market is open for trading.

 

Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange (or any successors to any of the foregoing).

 

Transaction Documents” means this Agreement, the Warrants, the Investor Agreement, the Lock-Up Agreements, the Placement Agent Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

Transfer Agent” means Continental Stock Transfer and Trust Company, the current transfer agent of the Company, with a mailing address of 17 Battery Place, 8th Floor, New York, NY 10004, and any successor transfer agent of the Company.

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Unregistered Warrants” means the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Warrants shall be exercisable on the six (6) month anniversary of date of issuance and have a term of exercise equal to five (5) years from date of initial exercisability, in the form of Exhibit B attached hereto.

 

Unregistered Warrant Shares” means the shares of Common Stock issuable upon exercise of the Unregistered Warrants.

 

4
 

 

Warrants” means, collectively, the Pre-Funded Warrants, Registered Warrants and Unregistered Warrants.

 

Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants.

 

ARTICLE II.

PURCHASE AND SALE

 

2.1 Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $20 million of Shares, Pre-Funded Warrants, Registered Warrants and Unregistered Warrants; provided, however, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser’s Affiliates, and any Person acting as a group together with such purchaser or any of such Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation, in lieu of purchasing Shares, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The “Beneficial Ownership Limitation” shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Each Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for “Delivery Versus Payment” settlement with the Company or its designees. The Company shall deliver to each Purchaser its respective Shares, Prefunded Warrants, Registered Warrants and Unregistered Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Sullivan or such other location as the parties shall mutually agree. The Company covenants that, if any Purchaser delivers a Notice of Exercise (as defined in the Pre-Funded Warrant) no later than 12:00 p.m. (New York City time) on the Closing Date to exercise any Pre-Funded Warrants between the date hereof and the Closing Date, the Company shall deliver Pre-Funded Warrant Shares to the Purchaser on the Closing Date in connection with such Notice of Exercise. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via “Delivery Versus Payment” (“DVP”) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers’ names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).

 

2.2 Deliveries.

 

(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

 

(i) this Agreement duly executed by the Company;

 

(ii) a legal opinion of Company Counsel, in a form reasonably acceptable to the Purchaser and the Placement Agent;

 

(iii) the Company shall have provided each Purchaser with the Company’s wire instructions, on Company letterhead and executed by the Company’s Chief Executive Officer or Chief Financial Officer;

 

(iv) subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (“DWAC”) Shares equal to such Purchaser’s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;

 

5
 

 

(v) for each Purchaser of Pre-Funded Warrants, Pre-Funded Warrants registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser’s Subscription Amount applicable to the Pre-Funded Warrants divided by the Per Share Purchase Price, with an exercise price equal to $0.01 subject to adjustment therein; and

 

(vi) a Registered Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser’s Shares and/or shares of Common Stock issuable upon the exercise of Pre-Funded Warrants, with an exercise price equal to $0.70, subject to adjustment therein, up to an amount of shares of Common Stock within the Company’s authorized and unissued balance of shares of Common Stock, and to the extent the Company has no further authorized and unissued shares of Common Stock, the balance of such warrant shall be issued in an Unregistered Warrant;

 

(vii) the Lock-Up Agreements; and

 

(viii) the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).

 

(b) On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i) this Agreement duly executed by such Purchaser;

 

(ii) the Investor Agreement executed by such Purchaser; and

 

(iii) such Purchaser’s Subscription Amount, which shall be made available for “Delivery Versus Payment” settlement with the Company or its designees.

 

2.3 Closing Conditions.

 

(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and

 

(iii) the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:

 

(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

 

(iii) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

6
 

 

(iv) there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v) from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1 Representations and Warranties of the Company. Except as set forth in the Registration Statement and the Prospectus or in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:

 

(a) Subsidiaries. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

(a) Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”); provided that a change in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse Effect. No Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(b) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

7
 

 

(c) No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(d) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the notice of supplemental listing to the Trading Market for the listing of the Shares and Warrant Shares for trading thereon, (iv) filings required in Section 4.20 and the related Stockholder Approval to be received at the applicable Meeting and (v) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

(e) Issuance of the Securities; Registration. Except with respect to the Unregistered Warrant Shares, the Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. Except with respect to the Unregistered Warrant Shares, the Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. Except with respect to the Unregistered Warrant Shares, the Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on August 30, 2018 (the “Effective Date”), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The proposed sale of the Shares shall be made pursuant to General Instruction I.B.1. of Form S-3. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

8
 

 

(f) Capitalization. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(f), which Schedule 3.1(f) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth on Schedule 3.1(f), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers and the Placement Agent) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals, and other than any required approvals relating to the Unregistered Warrant Shares, no further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

(g) SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports complied in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

9
 

 

(h) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth on Schedule 3.1(h), (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity compensation or stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(h), no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.

 

(i) Litigation. Except as reported in the SEC Reports, there is no material action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”). None of the Actions set forth in the SEC Reports (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(j) Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

10
 

 

(k) Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(l) Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(m) Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

(n) Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except where the failure to be in compliance would not reasonably be expected to have a Material Adverse Effect.

 

11
 

 

(o) Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.

 

(p) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

(q) Transactions With Affiliates and Employees. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.

 

(r) Sarbanes-Oxley; Internal Accounting Controls. The Company and the Subsidiaries are in compliance in all material respects with the applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

 

12
 

 

(s) Certain Fees. Except as set forth in the Prospectus Supplement, no brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.

 

(t) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(u) Registration Rights. Except as set forth on Schedule 3.1(u), no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(v) Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set forth on Schedule 3.1(v), the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance in all material respects with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

 

(w) Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities and the Purchasers’ ownership of the Securities.

 

(x) Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

13
 

 

(y) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the Warrants or Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.

 

(z) [Reserved].

 

(aa) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

 

(bb) Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.

 

(cc) Accountants. The Company’s independent registered public accounting firm is set forth on Schedule 3.1(cc) of the Disclosure Schedules. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report for the fiscal year ending October 31, 2021.

 

(dd) Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

14
 

 

(ee) Acknowledgment Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(e) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company’s publicly-traded securities; (iii) any Purchaser, and counter-parties in “derivative” transactions to which any such Purchaser is a party, directly or indirectly, presently may have a “short” position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities (in material compliance with applicable laws) at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.

 

(ff) Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company’s placement agent in connection with the placement of the Securities.

 

(gg) FDA. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested and/or distributed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested and/or distributed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

 

15
 

 

(hh) Stock Option Plans. Each stock option granted by the Company under the Company’s stock option plan was granted (i) in accordance with the terms of the Company’s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.

 

(ii) Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(jj) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s request.

 

(kk) Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(ll) Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

(mm) Other Covered Persons. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.

 

(nn) Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Unregistered Warrants or the Unregistered Warrant Shares by the Company to the Purchasers as contemplated hereby.

 

(oo) No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Warrant or Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Warrants and Warrant Shares for sale only to the Purchasers and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

16
 

 

(pp) No Disqualification Events. With respect to the Warrant and Warrant Shares to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.

 

(qq) Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

 

3.2 Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):

 

(a) Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b) Understandings or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser understands that the Warrants and the Warrant Shares are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).

 

17
 

 

(c) Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Unregistered Warrants, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.

 

(d) Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e) Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.

 

(f) Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities of the Company in order for such Purchaser (or its broker or other financial representative) to effect Short Sales or similar transactions in the future.

 

(g) General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.

 

The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.

 

18
 

 

ARTICLE IV.
OTHER AGREEMENTS OF THE PARTIES

 

4.1 Removal of Legends.

 

(a) The Unregistered Warrants and Unregistered Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Unregistered Warrants or Unregistered Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Warrant under the Securities Act.

 

(b) The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Unregistered Warrants or Unregistered Warrant Shares in the following form:

 

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

(c) The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Unregistered Warrants or Unregistered Warrant Shares to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Unregistered Warrants or Unregistered Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Unregistered Warrants and Unregistered Warrant Shares may reasonably request in connection with a pledge or transfer of the Unregistered Warrants or Unregistered Warrant Shares.

 

19
 

 

(d) Certificates evidencing the Unregistered Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such Unregistered Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Unregistered Warrants), or (iii) if such Unregistered Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Unregistered Warrants), or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively; provided, however, that all reasonably required documentation relating to Rule 144 representations and warranties are received from the Purchaser. If all or any portion of an Unregistered Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Unregistered Warrant Shares, if such Unregistered Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Unregistered Warrants) or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Unregistered Warrant Shares shall be issued free of all legends. The Company agrees that following such time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Unregistered Warrant Shares, as applicable, issued with a restrictive legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Unregistered Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Unregistered Warrant Shares issued with a restrictive legend.

 

(e) In addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of Unregistered Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such Purchaser’s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the “Buy-In Price”) over the product of (A) such number of Unregistered Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Unregistered Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this Section 4.1(d).

 

4.2 Furnishing of Information.

 

(a) Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.

 

20
 

 

(b) At any time during the period commencing from the date hereof and ending at such time that all of the Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public Information Failure”) then, in addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Warrant Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser’s Warrants on the day of a Public Information Failure and on every thirtieth (30th) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer the Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

4.3 Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Unregistered Warrants or Unregistered Warrant Shares or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

 

4.4 Securities Laws Disclosure; Publicity. The Company shall (a) by the Disclosure Time issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).

 

4.5 Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.

 

21
 

 

4.6 Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser’s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such material non-public information with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.

 

4.7 Use of Proceeds. Except as set forth in the Prospectus Supplement, the Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in the ordinary course of the Company’s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.

 

4.8 Indemnification of Purchasers. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in connection with any registration statement of the Company providing for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

 

22
 

 

4.9 Reservation of Common Stock. As of the date hereof, other than with respect to the Unregistered Warrant Share, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.

 

4.10 Listing of Common Stock. For as long as the Warrants are outstanding and exercisable, the Company hereby agrees to use commercially reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and prior to the Closing, the Company submit a notice of supplemental listing for the Shares and the Warrant Shares on such Trading Market and use commercially reasonable efforts to promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. For so long as the Company maintains a listing or quotation of the Common Stock on a Trading Market, the Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.

 

4.11 Reserved.

 

4.12 Subsequent Equity Sales. From the date hereof until 60 days after the Closing Date (such applicable period, the “Restricted Period”), neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. From the date hereof until 90 days after the Closing Date (such applicable period, the “Additional Restricted Period”), neither the Company nor the Subsidiary shall conduct any sales from the Company’s Sales Agreement with the Placement Agent or any equity line transaction. Notwithstanding the foregoing, if still in effect, the Restricted Period and the Additional Restricted Period shall expire and terminate 30 days immediately following the date of effectiveness of the Registration Statement to be filed by the Company pursuant to Section 4.19 below.

 

4.13 Equal Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

 

23
 

 

4.14 Certain Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

 

4.15 Capital Changes. Except as set forth in the Company’s preliminary proxy statement filed with the SEC on April 2, 2021, until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares, provided that no consent shall be required in the event the Company undertakes a reverse stock split for purposes of maintaining the listing of the Common Stock on the Trading Market.

 

4.16 Lock-Up. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any officer or director that is a party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.

 

4.17 Exercise Procedures. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.18 Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Unregistered Warrant and Unregistered Warrant Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Warrant and Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.

 

24
 

 

4.19 Registration Statement. The Company shall use commercially reasonable best efforts to file a registration statement on Form S-3 (or other appropriate form) providing for the resale by the Purchasers of the Unregistered Warrant Shares issued and issuable upon exercise of the Unregistered Warrants as soon as practicable (and in any event within 60 calendar days of the such date, if ever, that the Company files an amendment to its certificate of incorporation to increase the number of authorized shares of common stock thereunder). The Company shall use commercially reasonable best efforts to cause such registration to become effective within 90 calendar days (or, in the event of a full review, 120 calendar days) following such date, if ever, that the Company files an amendment to its certificate of incorporation to increase the number of authorized shares of common stock thereunder and to keep such registration statement effective at all times until no Purchaser owns any Warrants or Warrant Shares issuable upon exercise thereof.

 

4.20 Proxy Statement; Stockholder Meeting. The Company agrees to promptly prepare a proxy statement (the “Proxy Statement”) to be sent to the Company’s stockholders in connection with a special or annual meeting of holders of the Company’s Common Stock (the “Meeting”), to be held for the purpose of seeking the Stockholder Approval described herein and for such other purposes within the sole discretion of the Company, and use its best efforts to obtain the Stockholder Approval. If the Stockholder Approval is not obtained at the Meeting, or any subsequent meeting, the Company shall subsequently file an additional Proxy Statement no later than 90 days after the Meeting, or subsequent meeting, at which such Stockholder Approval is not received, in order to seek Stockholder Approval and use its best efforts to obtain the Stockholder Approval.

 

ARTICLE V.
MISCELLANEOUS

 

5.1 Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).

 

5.2 Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

 

5.3 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

25
 

 

5.5 Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 66.6% in interest of the Shares based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.

 

5.6 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

5.7 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

 

5.8 No Third-Party Beneficiaries. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.

 

5.9 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

5.10 Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for a period of five (5) years from the Closing.

 

26
 

 

5.11 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

5.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

5.13 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser’s right to acquire such shares pursuant to such Purchaser’s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

5.14 Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.15 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate. Each party agrees that it shall not have a remedy of punitive or consequential damages against the other and hereby waives any right or claim to punitive or consequential damages it may now have or may arise in the future.

 

5.16 Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

27
 

 

5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.

 

5.18 Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

 

5.19 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

5.20 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

5.21 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

28
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

ADVAXIS, Inc.   Address for Notice:
    9 Deer Park Drive, Suite K-1, Monmouth Junction, NJ 08852
By: /s/ Kenneth A. Berlin    
Name:  Kenneth A. Berlin   E-mail: berlin@advaxis.com
Title: President and Chief Executive Officer and Interim Chief Financial Officer    

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

29
 

 

[PURCHASER SIGNATURE PAGES TO ADXS SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Purchaser: Lincoln Park Capital Fund, LLC

 

Signature of Authorized Signatory of Purchaser: /s/ Joshua Scheinfeld

 

Name of Authorized Signatory: /s/ Joshua Scheinfeld

 

Title of Authorized Signatory: President

 

Email Address of Authorized Signatory: ______________________________________

 

Facsimile Number of Authorized Signatory: ______________________________________

 

Address for Notice to Purchaser:

 

Lincoln Park Capital

440 N. Wells St. Suite 410

Chicago, IL 60654

 

Address for Delivery of Warrants to Purchaser (if not same as address for notice):

 

 

DWAC for Shares:

 

Subscription Amount: $ 2,999,999.54

 

Shares: 3,787,400

 

Pre-Funded Warrant Shares: 0

 

Warrant Shares: 3,787,400

 

Registered Warrant Shares: 1,682,730

 

Unregistered Warrant Shares: 2,104,670

 

EIN Number: ____________________

 

30
 

 

[PURCHASER SIGNATURE PAGES TO ADXS SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Purchaser: Armistice Capital Master Fund Ltd.

 

Signature of Authorized Signatory of Purchaser: /s/ Steven Boyd

 

Name of Authorized Signatory: Steven Boyd

 

Title of Authorized Signatory: CIO of Armistice Capital, LLC, the Investment Manager

 

Email Address of Authorized Signatory:_________________________________________

 

Facsimile Number of Authorized Signatory: ______________________________________

 

Address for Notice to Purchaser:

 

c/o Armistice Capital, LLC

510 Madison Avenue, 7th Floor

New York, NY 10022

 

Address for Delivery of Warrants to Purchaser (if not same as address for notice):

 

 

DWAC for Shares:

 

Subscription Amount: $16,992,328.36

 

Shares: 13,790,000

 

Pre-Funded Warrant Shares: 7,671,937 (with 4.99 percent blocker)

 

Registered Warrant Shares: 9,561,405 (w 4.99 percent blocker)

 

Unregistered Warrant Shares: 11,900,532 (w 4.99 percent blocker)

 

EIN Number: ____________________

 

31
 

 

EXHIBIT A

 

FORM OF WARRANT

 

32
 

 

EXHIBIT B

 

FORM OF UNREGISTERED WARRANT

 

33
 

 

EXHIBIT C

 

FORM OF PRE-FUNDED WARRANT

 

34
 

 

EXHIBIT D

 

FORM OF INVESTOR AGREEMENT

 

35
 

 

DISCLOSURE SCHEDULE

 

to

 

SECURITIES PURCHASE AGREEMENT

 

between

 

ADVAXIS, INC.

 

and

 

THE PURCHASERS IDENTIFIED THEREIN

 

dated as of

 

April 12, 2021

 

36
 

 

INTRODUCTION TO DISCLOSURE SCHEDULE

 

This Disclosure Schedule is made and given, in connection with the execution and delivery of that certain Securities Purchase Agreement (the “Purchase Agreement”), dated as of April 12, 2021, entered into between the Company and the several Purchasers named therein, for which A.G.P./Alliance Global Partners acted as placement agent (the “Placement Agent”). All capitalized terms used but not defined herein shall have the meanings as defined in the Purchase Agreement, unless otherwise provided. The schedule numbers below correspond to the section numbers of the representations and warranties in the Purchase Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Purchase Agreement where such disclosure would be appropriate and such appropriateness is reasonably apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Purchase Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Purchase Agreement require the consent of third parties and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item.

 

37
 

 

Schedule 3.1(f)

Capitalization

 

   (in thoushands) 
   1/31/2021 
Cash and Cash Equivalents   33,318 
Preferred stock, $0.001 par value; 5,000,000 shares authorized; Series B Preferred Stock; 0 shares issued and outstanding at January 31, 2021 and as adjusted; Liquidation preference of $0 at January 31, 2021.   0 
Common stock, $0.001 par value; 170,000,000 shares authorized, 116,130,688 shares issued and outstanding at January 31, 2021 and shares issued and outstanding as adjusted.   116 
Accumulated deficit   (414,715)
Total stockholders’ equity   37,575 
Total liabilities   8,372 

 

Security Ownership of Certain Beneficial Owners and Management

 

The following table sets forth information regarding the beneficial ownership of our common stock by (a) each person who is known to us to be the owner of more than five percent (5%) of our common stock, (b) each of our directors, (c) each of the named executive officers, and (d) all directors and executive officers and executive employees as a group. For purposes of the table, a person or group of persons is deemed to have beneficial ownership of any shares that such person has the right to acquire within 60 days of March 29, 2021. The percentage of ownership is based on 120,382,668 shares outstanding as of March 29, 2021. Unless otherwise indicated by footnote, the address for each of the beneficial owners set forth in the table below is c/o Advaxis, Inc., 9 Deer Park Drive, Suite K-1, Monmouth Junction, NJ 08852.

 

Name of Beneficial Owner  Total # of Shares Beneficially Owned   Percentage of Ownership  
Kenneth Berlin (1)   124,777    * %
Igor Gitelman (2)   -    * %
David Sidransky (3)   25,021    * %
Roni Appel (4)   29,170    * %
Richard Berman (5)   20,623    * %
Samir Khleif (6)   24,084    * %
James Patton (7)   36,389    * %
Andres Gutierrez (8)   50,973    * %
All Current Directors and Officers as a Group (8 People) (9)   305,481    * %
Molly Henderson (10)   5,833    * %
Renaissance Technologies LLC (11)   6,069,343    5.04 %

 

*Less than 1%

 

(1) Represents 16,111 issued shares of our Common Stock, 5,555 restricted stock units that vest within 60 days, and options to purchase 103,111 shares of our Common Stock exercisable within 60 days.

 

(2) Mr. Gitelman’s options are not exercisable within 60 days.

 

38
 

 

(3) Represents 7,355 issued shares of our Common Stock and options to purchase 17,666 shares of our Common Stock exercisable within 60 days.

 

(4) Represents 10,476 issued shares of our Common Stock, options to purchase 16,805 shares of our Common Stock exercisable within 60 days and warrants to purchase 1,889 shares of our Common Stock exercisable within 60 days.

 

(5) Represents 3,711 issued shares of our Common Stock and options to purchase 16,912 shares of our Common Stock exercisable within 60 days.

 

(6) Represents 4,639 issued shares of our Common Stock and options to purchase 19,445 shares of our Common Stock exercisable within 60 days.

 

(7) Represents 19,117 issued shares of our Common Stock and options to purchase 17,272 shares of our Common Stock exercisable within 60 days.

 

(8) Represents 3,750 issued shares of our Common Stock and options to purchase 47,223 shares of our Common Stock exercisable within 60 days.

 

(9) Represents 70,715 issued shares of our Common Stock and options to purchase 238,434 shares of our Common Stock exercisable within 60 days and warrants to purchase 1,889 shares of our Common Stock exercisable within 60 days.

 

(10) Represents 5,833 issued shares of our Common Stock. Ms. Henderson resigned as the Company’s Chief Financial Officer effective September 25, 2020.

 

(11) Represents 6,069,343 issued shares of our Common Stock. The address for Renaissance Technologies LLC is 800 Third Avenue, New York, New York 10022. Information is derived in part from Schedule 13G/A filed on February 11, 2021.

 

39
 

 

Schedule 3.1(h)
Material Changes; Undisclosed Events, Liabilities or Developments

 

None.

 

40
 

 

Schedule 3.1(u)

Registration Rights

 

None.

 

41
 

 

Schedule 3.1(v)

Listing and Maintenance Requirements

 

In order to maintain listing on the Nasdaq Capital Market, we must satisfy minimum financial and other requirements including, without limitation, a requirement that our closing bid price be at least $1.00 per share. On April 8, 2020, the Company received written notice from Nasdaq indicating that the Company was not in compliance with this minimum bid price requirement because the Company’s common stock had closed below $1.00 per share for the previous 30 consecutive business days. On April 17, 2020, the Company received an additional notice from Nasdaq indicating that, due to extraordinary market conditions, Nasdaq had tolled the compliance period for the bid-price requirement through June 30, 2020 (the “tolling period”) and that on April 16, 2020, Nasdaq filed an immediately effective rule change with the SEC to implement the tolling period. In accordance with the April 17, 2020 notice from Nasdaq, the Company had until December 21, 2020 to regain compliance with the minimum bid price requirement.

 

As of December 21, 2020, the Company was yet to be in compliance with the minimum bid requirement as discussed above. On December 22, 2020, the Company received notification from the Nasdaq that the Company’s application to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market had been approved. The Company’s securities were transferred to the Nasdaq Capital Market at the opening of business on December 24, 2020 and the Company will have an additional 180 days, or until June 21, 2021, to regain compliance with the minimum bid price per share requirement.

 

If compliance cannot be demonstrated by June 21, 2021 or the Company does not comply with the terms of this extension, Nasdaq will provide written notification that the Company’s securities will be delisted.

 

42
 

 

Schedule 3.1(cc)

Auditors

 

Marcum LLP.

 

43

 

 

Exhibit 10.2

 

Execution Version

 

FORM OF INVESTOR AGREEMENT

 

April 12, 2021

 

This agreement (the “Investor Agreement”) is being delivered to you in connection with an understanding by and between Advaxis Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).

 

Reference is hereby made to the Securities Purchase Agreement, dated April 12, 2021, by and among the Company the certain purchasers signatory thereto (the “SPA”) pursuant to which the acquired shares (the “Shares”) of common stock, $0.001 par value per share, of the Company (the “Common Stock”). Capitalized terms not defined herein shall have the meaning as set forth in the SPA, unless otherwise set forth herein.

 

The Holder agrees solely with the Company that starting at the time of the public announcement of the final pricing (the “Effective Date”) and ending at 11:59 pm (New York City time) on April 15, 2021 (such period, the “Restricted Period”), neither the Holder, nor any affiliate of such Holder which (x) had or has knowledge of the transactions contemplated by the SPA, (y) has or shares discretion relating to such Holder’s investments or trading or information concerning such Holder’s investments, including in respect of the Shares, or (z) is subject to such Holder’s review or input concerning such affiliate’s investments or trading (together, the “Holder’s Trading Affiliates”), collectively, shall sell, dispose or otherwise transfer, directly or indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that would be equivalent to any sales or short positions) on any Trading Day during the Restricted Period (any such date, a “Date of Determination”), any shares of Common Stock of the Company, or shares of Common Stock of the Company underlying any convertible securities or options, held by the Holder on the date hereof (collectively, the “Restricted Securities”).

 

Notwithstanding anything herein to the contrary, during the Restricted Period, the Holder may, directly or indirectly, sell or transfer all, or any part, of any Restricted Securities to any Person (an “Assignee”) in a transaction which does not need to be reported on the Nasdaq consolidated tape without complying with (or otherwise limited by) the restrictions set forth in this Investor Agreement; provided, that as a condition to any such sale or transfer an authorized signatory of the Company and such Assignee duly execute and deliver an agreement in the form of this Investor Agreement (an “Assignee Agreement”, and each such transfer a “Permitted Transfer”) and, subsequent to a Permitted Transfer, sales of the Holder and the Holder’s Trading Affiliates and all Assignees (other than any such sales that constitute Permitted Transfers) shall be aggregated for all purposes of this Investor Agreement and all Assignee Agreements.

 

In addition to the foregoing, the Holder acknowledges that on or about June 3, 2021, the Company intends to hold its annual meeting of stockholders (the “Meeting”) at which the Company’s stockholders of record as of April 15, 2021 (the “Record Date”) shall be asked (i) to elect six members to the Company’s Board of Directors to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified, subject to their earlier resignation or removal; (ii) to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (as amended to date, the “Charter”) to increase the number of authorized shares of common stock, $0.001 par value per share from 170,000,000 shares to 300,000,000 shares; (iii) to approve an amendment to the Charter to effect a reverse stock split of the Company’s common stock at a ratio determined by the Board of Directors within a range of one-for-five to one-for-fifteen, without reducing the authorized number of shares of the Company’s common stock, to be effected in the sole discretion of the Board of Directors at any time within one year of the date of the Meeting without further approval or authorization of the Company’s stockholders; (vi) to approve an amendment to the Company’s 2015 Incentive Plan (the “2015 Incentive Plan”) to increase the existing per-participant annual award limitations included therein; (v) to ratify and approve the prior amendment to the Company’s 2015 Incentive Plan, which was adopted following the 2020 Annual Meeting of Stockholders, to increase the total number of shares of common stock authorized for issuance thereunder from 877,744 shares to 6,000,000 shares; and (vi) to ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2021 (clauses (i)through (vi) collectively referred to as the “Proposals”).

 

1
 

 

The Holder, solely in its capacity as a stockholder of the Company, agrees to vote (or cause to be voted) all of the Shares of Common Stock that it either owns or that it has or shares discretion to vote as of the Record Date, at the Meeting or any adjournment thereof, and/or in any action by written consent of the stockholders of the Company, in a manner consistent with the recommendation of the Board of Directors on each of (i) the Proposals, (ii) any other matter relating to the Proposals, and (iii) any matter in which the Board of Directors of the Company recommends that stockholders approve at the Meeting. The Holder hereby agrees not to grant any proxy with respect to such shares of Common Stock or to enter into or agree to be bound by any voting trust or agreement or other arrangement of any kind that is inconsistent with the provisions of this Agreement. The Holder agrees not to revoke any such vote or change any vote once voted in a manner consistent with the recommendation of the Board of Directors on each of the Proposals.

 

Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Investor Agreement must be in writing and shall be given in accordance with the terms of the SPA; provided that with respect to any notices, consents, waivers or other communications to be made by the Company to the Holder, such notice, consent, waiver or other communication shall be delivered to the Holder at the facsimile number or e-mail address provided on the signature page hereto.

 

This Investor Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations, letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.

 

This Investor Agreement may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such counterparts shall constitute one and the same instrument. This Investor Agreement may be executed and accepted by facsimile or PDF signature and any such signature shall be of the same force and effect as an original signature.

 

The terms of this Investor Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors and assigns.

 

This Investor Agreement may not be amended or modified except in writing signed by each of the parties hereto.

 

All questions concerning the construction, validity, enforcement and interpretation of this Investor Agreement shall be governed by the applicable provisions of the SPA.

 

Each party hereto acknowledges that, in view of the uniqueness of the transactions contemplated by this Investor Agreement, the other party or parties hereto may not have an adequate remedy at law for money damages in the event that this Investor Agreement has not been performed in accordance with its terms, and therefore agrees that such other party or parties shall be entitled to seek specific enforcement of the terms hereof in addition to any other remedy it may seek, at law or in equity.

 

The Holder acknowledges that AGP has acted as and the placement agent for the Placement. The obligations of the Holder under this Investor Agreement are several and not joint with the obligations of any other holder of any of the Shares issued under the SPA (each, an “Other Holder”) or any other holder of any of the Shares issued under the Registration Statement that is not a signatory to the SPA (each, a “Prospectus Purchaser Other Holder”) under any other agreement, and the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder or any Prospectus Purchaser Other Holder under any such other agreement. Nothing contained herein or in this Investor Agreement, and no action taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and Other Holders or any Prospectus Purchaser Other Holder as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holder and the Other Holders or any Prospectus Purchaser Other Holder are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Investor Agreement and the Company acknowledges that the Holder and the Other Holders or any Prospectus Purchaser Other Holder are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this Investor Agreement or any other agreement. The Company and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Investor Agreement, and it shall not be necessary for any Other Holder or any Prospectus Purchaser Other Holder to be joined as an additional party in any proceeding for such purpose.

 

The Company hereby represents and warrants as of the date hereof and covenants and agrees from and after the date hereof that none of the terms offered to any Other Holder or any Prospectus Purchaser Other Holder that purchases the Shares in the Placement settlement with respect to any restrictions on the sale of Shares substantially in the form of this Investor Agreement (or any amendment, modification, waiver or release thereof) (each a “Settlement Document”), is or will be more favorable to such Other Holder than those of the Holder and this Investor Agreement. If, and whenever on or after the date hereof, the Company enters into a Settlement Document with terms that are materially different from this Investor Agreement, then (i) the Company shall provide notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this Investor Agreement shall be, without any further action by the Holder or the Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Settlement Document, provided that upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term or condition contained in this Investor Agreement shall apply to the Holder as it was in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect to the Holder. The provisions of this paragraph shall apply similarly and equally to each Settlement Document.

 

[The remainder of the page is intentionally left blank]

 

2
 

 

The parties hereto have executed this Investor Agreement as of the date first set forth above.

 

  Sincerely,
   
  ADVAXIS, INC.
     
  By:  
  Name: Kenneth A. Berlin
  Title: President and Chief Executive Officer and Interim Chief Financial Officer

 

Agreed to and Accepted:  
“HOLDER”  
     
   
              
By:  
Name:  
Title:  
Fax Number:  
Email Address:  

 

ACKNOWLEDGED:  
   
A.G.P./Alliance Global Partners  
     
By:           
Name: Thomas J. Higgins  
Title: Managing Director  

 

3

 

="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"H="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"M="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"H="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"D="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"I="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"I="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"H="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"D="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"B="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"D="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"&="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"B="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"B="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"&="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"I="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"M="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"G="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"C="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"_="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"j="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"v="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"v="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"3="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"7="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"4="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"3="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"5="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"2="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"2="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"8="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"3="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"|="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"9="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"_="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"j="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"6="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"3="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"2="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"8="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"&="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"b="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"z="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"B="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"v="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"x="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"I="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg".="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"$="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"2="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"M="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"D="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"c="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"A="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"h="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"-="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"M="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"k="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"U="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"d="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"q="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"u="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"l="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"B="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"F="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"O="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"/="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg">="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"<="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"P="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"Y="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"L="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"E="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"=="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg""="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"1="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"N="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"w="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"R="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"o="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"T="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"s="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg",="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"S="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"e="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"f="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg";="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"m="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"a="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"r="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"g="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"i="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"n="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg":="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg" ="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"0="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"p="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|1100397|000149315220000983|ex99-1_001.jpg"t="https://cdn.kscope.io/7743c13418d5292034d34bc08ccd0b21-https:||www.sec.gov|Archives|edgar|data|110